PSP Research »

Kalvista Pharmaceuticals shares owned by PSP Research

Quarter-by-quarter ownership of Kalvista Pharmaceuticals (KALV) shares owned by PSP Research from 13F filings

Historical chart of PSP Research investment in Kalvista Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Kalvista Pharmaceuticals held by PSP Research consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kalvista Pharmaceuticals by PSP Research

Quarter filed Position value Share count Share price at filing
2026-03-31 $217k 11k 20.13

More positions owned by PSP Research

Ishares Tr 0-3 Mnth Treasry (SGOV)
Spdr Series Trust State Street Spd (XBI)
Sera Prognostics Class A Com (SERA)
Definium Therapeutics Com Shs (DFTX)
Tyra Biosciences (TYRA)
Ascendis Pharma A/s Sponsored Adr (ASND)
Pharvaris N V (PHVS)
Cytokinetics Com New (CYTK)
Royalty Pharma Shs Class A (RPRX)
Kymera Therapeutics (KYMR)
Halozyme Therapeutics (HALO)
Exelixis (EXEL)
Disc Medicine (IRON)
Ionis Pharmaceuticals (IONS)
Agios Pharmaceuticals (AGIO)

View all positions for PSP Research

Top funds holding Kalvista Pharmaceuticals

VR Adviser
Frazier Life Sciences Management
Suvretta Capital Management
Tang Capital Management
BlackRock
Millennium Management
Capital World Investors
Vanguard Group
Silverarc Capital Management
Point72 Asset Management
Woodline Partners
State Street Corporation
Vestal Point Capital
Vanguard Capital Management
Kynam Capital Management

View all funds holding Kalvista Pharmaceuticals